| Politician | Action | Description | Traded |
|---|---|---|---|
| Sell | ELANCO ANIMAL HEALTH INCORPO | Aug 4, 2026 | |
| Sell | Elanco Animal Health Incorpo | Sep 23, 2025 | |
| Sell | ELANCO ANIMAL HEALTH INCORPO | Sep 22, 2025 | |
| Sell | ELANCO ANIMAL HEALTH INCORPO | Jun 10, 2025 | |
| Sell | ELANCO ANIMAL HEALTH INCORPO | May 12, 2025 | |
| Sell | ELANCO ANIMAL HEALTH INCORPO | May 8, 2025 | |
| Buy | ELANCO ANIMAL HEALTH INCORPO | Apr 10, 2025 | |
| Sell | ELANCO ANIMAL HEALTH INCORPO | Jan 17, 2025 | |
| Buy | ELANCO ANIMAL HEALTH INCORPO | Jan 17, 2025 | |
| Buy | ELANCO ANIMAL HEALTH INCORPO | Dec 16, 2024 |
This page tracks congressional stock trading activity in Elanco Animal Health Incorporated (ELAN) in the Healthcare sector. Disclosed Capitol has indexed 65 disclosed congressional trades involving ELAN. Every trade is sourced from official STOCK Act financial disclosure filings — the same primary records the Senate and House are required to publish. The full trade list with politician names, transaction types, amount ranges, and disclosure dates is below, alongside cross-references to any related lobbying activity, federal contracts, and committee assignments.
As of September 2026 — Disclosed Capitol has tracked 65 disclosed congressional trades in Elanco Animal Health Incorporated (ELAN) — 28:24 sell-heavy ratio — led by Ro Khanna (D).
| Date | Politician | Party | Action | Amount |
|---|---|---|---|---|
| Aug 4, 2026 | Ro Khanna | D | Sell | $1,001 - $15,000 |
| Sep 23, 2025 | Valerie Hoyle | D | Sale | $1,001 - $15,000 |
| Sep 22, 2025 | Ro Khanna | D | Sale | $1,001 - $15,000 |
| Jun 10, 2025 | Ro Khanna | D | Sale | $1,001 - $15,000 |
| May 12, 2025 | Ro Khanna | D | Sale | $1,001 - $15,000 |
| May 8, 2025 | Ro Khanna | D | Sale | $1,001 - $15,000 |
| Apr 10, 2025 | Ro Khanna | D | Purchase | $1,001 - $15,000 |
| Jan 17, 2025 | Ro Khanna | D | Sale | $1,001 - $15,000 |
| Jan 17, 2025 | Ro Khanna | D | Purchase | $1,001 - $15,000 |
| Dec 16, 2024 | Ro Khanna | D | Purchase | $1,001 - $15,000 |
Across the 65 disclosed congressional trades in Elanco Animal Health Incorporated (ELAN), members of Congress have reported 24 buys and 28 sells. The average 30-day alpha vs. the S&P 500 is 1.63%.
For fiscal year 2025, Elanco Animal Health Incorporated reported revenue of $4.71B and net income of -$232.0M, per SEC filings.
Most recent reported quarter: Q2 FY2026 — revenue $2.74B, net income $111.0M.
Figures come from SEC financial statement filings. The full annual and quarterly statement history is in the Financials tab above.